Balyasny Asset Management’s GoodRx Holdings GDRX Stock Holding History

Balyasny Asset Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-370,310	Closed	-$726K	–	3186
2026 Q1	$726K	Sell	370,310 -78,722	-18%	-$185K	﹤0.01%	2211
2025 Q4	$1.22M	Buy	449,032 +220,012	+96%	+$722K	﹤0.01%	2098
2025 Q3	$969K	Sell	229,020 -17,197	-7%	-$75.6K	﹤0.01%	2125
2025 Q2	$1.23M	Sell	246,217 -1,644	-0.7%	-$7.14K	﹤0.01%	1967
2025 Q1	$1.09M	Buy	247,861 +60,831	+33%	+$286K	﹤0.01%	1952
2024 Q4	$870K	Buy	+187,030	New	+$1.03M	﹤0.01%	1993
2024 Q1	–	Sell	-85,527	Closed	-$573K	–	2793
2023 Q4	$573K	Buy	85,527 +27,115	+46%	+$153K	﹤0.01%	1895
2023 Q3	$329K	Sell	58,412 -368,376	-86%	-$2.46M	﹤0.01%	1878
2023 Q2	$2.36M	Buy	+426,788	New	+$2.3M	0.01%	1330

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Balyasny Asset Management's GDRX Position: Q2 2026 in Review

Balyasny Asset Management sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 370,310 shares — an estimated $726K sold.

Balyasny Asset Management first reported a position in GDRX in Q2 2023 and held it in 9 quarters. The position peaked at $2.36M in Q2 2023. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

Balyasny Asset Management reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
Balyasny Asset Management sold 370,310 GoodRx Holdings shares in Q2 2026, an estimated $726K.
Balyasny Asset Management first reported a position in GoodRx Holdings in Q2 2023 and held it in 9 quarters.
Balyasny Asset Management's GoodRx Holdings position peaked at $2.36M in Q2 2023.
162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.